Mary Wilson
Well-known member
Monoclonal antibody therapy can reduce COVID-19 symptoms, hospitalization or emergency room visits when administered as soon as possible after exposure or within 10 days of symptom onset.
70%-85% reduction in hospitalization and death in patients
80% reduction of infection among patients’ households
Exposed or tested positive for COVID-19? You may qualify for a new monoclonal antibody therapy (mAb) that will help protect you from infection and hospitalization.
This is an outpatient treatment, administered either intravenously or through injections. We offer this treatment free for qualifying individuals who have tested positive or been exposed to COVID-19.
Who is Eligible?
Approximately 85% of adult Americans who are exposed or test positive qualify for this treatment.
mAbs are authorized for use for people ages 12+, who have tested positive or been exposed to COVID-19 but are not hospitalized.
https://mabsathome.com
70%-85% reduction in hospitalization and death in patients
80% reduction of infection among patients’ households
Exposed or tested positive for COVID-19? You may qualify for a new monoclonal antibody therapy (mAb) that will help protect you from infection and hospitalization.
This is an outpatient treatment, administered either intravenously or through injections. We offer this treatment free for qualifying individuals who have tested positive or been exposed to COVID-19.
Who is Eligible?
Approximately 85% of adult Americans who are exposed or test positive qualify for this treatment.
mAbs are authorized for use for people ages 12+, who have tested positive or been exposed to COVID-19 but are not hospitalized.
https://mabsathome.com
